Physician profile
Prem Samuel
NPI 1043266380
$36,996.61
in general payments reported to CMS, 2019-2025
15 companies · $2,455 in 2025
The $2,455 reported for 2025 was more than what 95% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $6,201 · 2021: $4,718 · 2022: $6,216 · 2023: $192 · 2024: $1,708 · 2025: $2,455.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,193 · Travel and Lodging: $2,163.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,192.67 |
| Travel and Lodging | $2,162.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $26,716.36 | 2019-2025 | |
| Atricure, INC. | $2,859.61 | 2019-2025 | Epi-Sense Guided Coagulation System With Visitrax, Atricure Cryoice Cryoablation System (Cryo2), Synergy Ablation System |
| Artivion, INC. | $2,402.50 | 2022-2025 | Amds-Ascyrus Medical |
| Medtronic Vascular, INC. | $1,408.26 | 2019 | |
| Davol INC. | $855.24 | 2022-2025 | Tridyne Vascular Sealant, Arista |
| Bolton Medical INC | $814.95 | 2024 | Treo Abdominal Stent-Graft System |
| Zimmer Biomet Holdings, INC. | $684.47 | 2022 | |
| Abiomed | $655.92 | 2021-2025 | Impella |
| Edwards Lifesciences Corporation | $260.32 | 2019-2025 | Sapien 3 Ultra Resilia |
| Siemens Medical Solutions USA, INC. | $138.49 | 2024 | |
| Haemonetics Corporation | $94.21 | 2021 | |
| Medtronic, INC. | $37.09 | 2025 | Corevalve Evolut R |
| Astrazeneca Pharmaceuticals Lp | $35.12 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.99 | 2025 | |
| Genentech USA, INC. | $15.08 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prem Samuel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.